|36.00||+0.6200||+1.75%||Vol 1.15M||1Y Perf 1.67%|
|Aug 11th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||51.71||Analyst Rating||Hold 2.83|
|Potential %||43.64||Finscreener Ranking||★★+ 48.41|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★ 50.31|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★ 58.80|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★★ 40.11|
|Price Range Ratio 52W %||60.03||Earnings Rating||Strong Buy|
|Market Cap||5.58B||Earnings Date||28th Jul 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||1.42|
|EPS Growth Next 5 Years %||13.50|
|Avg. Weekly Volume||922.16K|
|Avg. Monthly Volume||1.23M|
|Avg. Quarterly Volume||1.54M|
Chemours Company (The) (NYSE: CC) stock closed at 36 per share at the end of the most recent trading day (a 1.75% change compared to the prior day closing price) with a volume of 1.15M shares and market capitalization of 5.58B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Chemicals industry, Basic Materials sector and employs 6500 people. Chemours Company (The) CEO is Mark P. Vergnano.
The one-year performance of Chemours Company (The) stock is 1.67%, while year-to-date (YTD) performance is 7.27%. CC stock has a five-year performance of -22.31%. Its 52-week range is between 22.56 and 44.947, which gives CC stock a 52-week price range ratio of 60.03%
Chemours Company (The) currently has a PE ratio of 7.00, a price-to-book (PB) ratio of 4.20, a price-to-sale (PS) ratio of 0.99, a price to cashflow ratio of 6.70, a PEG ratio of 2.32, a ROA of 10.44%, a ROC of 17.65% and a ROE of 75.79%. The company’s profit margin is 13.36%, its EBITDA margin is 20.10%, and its revenue ttm is $5.02 Billion , which makes it $32.28 revenue per share.
Of the last four earnings reports from Chemours Company (The), there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.42 for the next earnings report. Chemours Company (The)’s next earnings report date is -.
The consensus rating of Wall Street analysts for Chemours Company (The) is Hold (2.83), with a target price of $51.71, which is +43.64% compared to the current price. The earnings rating for Chemours Company (The) stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Chemours Company (The) has a dividend yield of 3.14% with a dividend per share of $1.00 and a payout ratio of 78.00%.
Chemours Company (The) has a Buy technical analysis rating based on Technical Indicators (ADX : 11.67, ATR14 : 1.30, CCI20 : 149.87, Chaikin Money Flow : -0.04, MACD : 0.45, Money Flow Index : 59.04, ROC : 5.82, RSI : 56.37, STOCH (14,3) : 51.84, STOCH RSI : 1.00, UO : 46.59, Williams %R : -48.16), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Chemours Company (The) in the last 12-months were: Alisha Bellezza (Option Excercise at a value of $259 527), Alisha Bellezza (Sold 14 365 shares of value $581 495 ), Alvenia Scarborough (Option Excercise at a value of $104 603), Alvenia Scarborough (Sold 7 249 shares of value $293 005 ), David C. Shelton (Option Excercise at a value of $1 605 829), David C. Shelton (Sold 160 534 shares of value $6 371 081 ), Edwin C. Sparks (Option Excercise at a value of $1 247 406), Edwin C. Sparks (Sold 62 932 shares of value $2 567 636 ), Mark E. Newman (Option Excercise at a value of $1 233 309), Mark E. Newman (Sold 66 846 shares of value $2 339 610 ), Mark P. Vergnano (Option Excercise at a value of $3 621 846), Mark P. Vergnano (Sold 196 306 shares of value $6 870 710 ), Sameer Ralhan (Option Excercise at a value of $925 338), Sameer Ralhan (Sold 89 313 shares of value $3 407 898 )
Thu, 19 May 2022 02:05 GMT Analysts Offer Insights on Materials Companies: Chemours Company (CC) and Clariant AG (OtherCLZNF)- TipRanks. All rights reserved.
Tue, 17 May 2022 12:55 GMT Analysts Are Bullish on These Materials Stocks: Chemours Company (CC), Equinox Gold (EQX)- TipRanks. All rights reserved.
Wed, 04 May 2022 12:40 GMT RBC Capital Believes Chemours Company (CC) Wont Stop Here- TipRanks. All rights reserved.
Tue, 03 May 2022 13:27 GMT Chemours Company (CC) Received its Third Buy in a Row- TipRanks. All rights reserved.
Mon, 02 May 2022 21:57 GMT Chemours Company (CC) Gets a Buy Rating from Alembic Global- TipRanks. All rights reserved.
Mon, 14 Feb 2022 14:48 GMT Chemours Company (CC) Gets a Buy Rating from BMO Capital- TipRanks. All rights reserved.
Thu, 10 Feb 2022 23:10 GMT Chemours Company (CC) Receives a Buy from Alembic Global- TipRanks. All rights reserved.
Fri, 28 Jan 2022 02:20 GMT Chemours Company (CC) Gets a Buy Rating from RBC Capital- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.